Clinical Correspondence and the Limits of Evidence Synthesis

Abstract

Clinical Correspondence and the Limits of Evidence Synthesis addresses a narrow but consequential interpretive problem: a commentary counted as a new clinical trial. This literature-based conceptual analysis does not report a new experiment. The starting source uses a JAMA correspondence contribution rather than a newly reported cohort or randomized intervention. A correspondence item can sharpen interpretation without adding independent observations. A review can assemble arguments without testing them directly. Classify sources before extracting conclusions. Require a primary study for numerical outcome claims and avoid multiplying evidence by counting commentary about the same experiment. The proposed comparison concerns letters, clinical reviews, primary cohorts; it would test whether the specific failure scenario is detected without erasing legitimate uncertainty. An integrated account should preserve the distinction between clinical correspondence and changing patient records and any stronger downstream decision.